Send a text

Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the safety and efficacy of lorundrostat (an aldosterone synthase inhibitor) in treatment of uncontrolled and treatment-resistant hypertension. Here we go!

1. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension (0:00 – 7:02).

The Good Stuff:

• Trial Files, a free monthly newsletter on practice-changing trials, delivered straight to your inbox. (7:03 - 7:50)

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods